Elsa Bernard
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Hematology 33
- Acute Myeloid Leukemia Research 32
-
- Genomics and Phylogenetic Studies 2
- Fibroblast Growth Factor Research 1
- Co-authors
- Olivier Mestre (1 shared paper)Mathieu Vrac (1 shared paper)Philippe Naveau (1 shared paper)Jean‐Philippe Vert (5 shared papers)Laurent Jacob (3 shared papers)Julien Mairal (3 shared papers)Jean-Louis Plouhinec (1 shared paper)Michael B. Eisen (1 shared paper)
- Journals
- Blood (7 papers)Clinical Cancer Research (4 papers)Blood Advances (4 papers)Nature Medicine (2 papers)Cancer Cell (2 papers)
- Partner nations
- United StatesFranceSweden
In The Last Decade
Elsa Bernard
47 papers receiving 2.9k citations
Elsa Bernard's Hit Papers
Peers
Comparison fields: 5 of 79
- Hematology 1.6k
- Cancer Research 112
- Oncology 124
- Genetics 45
- Health Informatics 7
Countries citing papers authored by Elsa Bernard
This map shows the geographic impact of Elsa Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Bernard more than expected).
Fields of papers citing papers by Elsa Bernard
This network shows the impact of papers produced by Elsa Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Bernard. The network helps show where Elsa Bernard may publish in the future.
Co-authors
The 25 scholars most cited alongside Elsa Bernard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular International Prognostic Scoring System for Myelodysplastic Syndromes Hit paper breakdown → | 2022 | 588 |
| 2 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis Hit paper breakdown → | 2020 | 559 |
| 3 | Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Hit paper breakdown → | 2020 | 510 |
| 4 | Embracing cancer complexity: Hallmarks of systemic disease Hit paper breakdown → | 2024 | 355 |
| 5 | Unified classification and risk-stratification in Acute Myeloid Leukemia Hit paper breakdown → | 2022 | 136 |
| 6 | 2013 | 92 | |
| 7 | 2021 | 82 | |
| 8 | 2014 | 59 | |
| 9 | Tumor-Infiltrating Clonal Hematopoiesis Hit paper breakdown → | 2025 | 51 |
| 10 | 2017 | 47 | |
| 11 | 2024 | 44 | |
| 12 | 2024 | 39 | |
| 13 | 2023 | 31 | |
| 14 | 2021 | 30 | |
| 15 | 2019 | 28 | |
| 16 | 2019 | 26 | |
| 17 | 2023 | 24 | |
| 18 | 2023 | 23 | |
| 19 | 2023 | 20 | |
| 20 | 2023 | 17 |
About Elsa Bernard
Elsa Bernard is a scholar working on Hematology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Computational Theory and Mathematics, having authored 54 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (32 papers), Genomics and Phylogenetic Studies (2 papers), Lung Cancer Treatments and Mutations (1 paper), Cancer Genomics and Diagnostics (1 paper), European and International Law Studies (1 paper), Advanced Breast Cancer Therapies (1 paper), Fibroblast Growth Factor Research (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Hematology (1.6k citations), Cancer Research (112 citations), Oncology (124 citations), Genetics (45 citations) and Health Informatics (7 citations). Elsa Bernard has collaborated with scholars based in United States, France and Sweden. Frequent co-authors include Olivier Mestre, Mathieu Vrac, Philippe Naveau, Jean‐Philippe Vert, Laurent Jacob, Julien Mairal, Jean-Louis Plouhinec, Michael B. Eisen, Sofía Medina-Ruiz and Richard M. Harland. Their work appears in journals such as Blood, Clinical Cancer Research, Blood Advances, Nature Medicine and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.